Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myelomaJoaquín Martínez‐López, Beatriz Sánchez-Vega, Santiago Barrio et al.|Leukemia|2017Cited by 51